Systemic arterial hypertension and associated factors in people with hiv/aids on antiretroviral therapy

This article aims at verifying the cumulative incidence of systemic arterial hypertension and associated factors in people with HIV/AIDS undergoing high-potency antiretroviral treatment. Epidemiological study of a retrospective cohort performed to patients with HIV/AIDS, attended at the Specialized Attention Service (SAE) in Ponta Grossa – Paraná, Brazil. The data were obtained by notification the records of diseases, injuries and medical records from 538 patients attended from January 2002 to December 2014. Most of the subjects were male, married, with 1-7 years of schooling, mean age at diagnosis of 36.6 years, and almost all of them were sexually infected and used some drug treatment. The mean incidence of hypertension was 24.4%. Subjects on antiretroviral therapy with a therapeutic regimen of association among Nucleotide Reverse Transcriptase Inhibitors, Non-Nucleotide Reverse Transcriptase Inhibitors and Protease Inhibitors showed a higher percentage of arterial hypertension. Age at diagnosis, weight, time, and the therapeutic regimen were able to explain 20.4% of blood pressure variability. It is concluded that hypertension in patients with HIV / AIDS and under antiretroviral therapy was associated with age at diagnosis, weight, time of treatment and therapeutic regimen.